A Hyderabad-based study reveals a sharp rise in women delaying motherhood beyond 35 years in urban centres. While reflecting changing priorities such as education and careers, doctors warn that ...

From superbugs and heart disease to pollution, junk food and smartphones, these ten major studies reveal how science is ...

Under the agreement, Biocon will supply semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Former U.S. Sen. Ben Sasse announced that he has been diagnosed with stage four pancreatic cancer. Doctors say treatment ...

Minnesota business icon and TV pitchman Dick Enrico died earlier this month at the age of 85. Perhaps best known for his ...

A large Swedish study reported a lower risk of dementia among middle-aged and older adults who consumed higher amounts of ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

A study led by biomedical scientists at the University of California, Riverside, has shown for the first time that a father's exposure to microplastics (MPs) can trigger metabolic dysfunctions in his ...

Novo Nordisk Stock Soars After Weight-Loss Pill Approved in U.S. What It Means for Eli Lilly.

On Dec. 23, 2025, investors weighed a newly approved oral obesity pill’s first-mover edge and its ripple effects across healthcare.

Holidays can disrupt routines and blood sugar. WVU Medicine Princeton Endocrinology says to set reminders, eat balanced meals ...